Q2 STOCKS TO BUY

bluebird bio Stock Bounces on Cancer Drug Update

Much of the stock's recent support stemmed from the rising 160-day moving average

Managing Editor
Jun 4, 2018 at 9:53 AM
facebook X logo linkedin


Biotech concern bluebird bio Inc (NASDAQ:BLUE) is higher in today's trading after the company reported data for its immunotherapy drug bb2121, which showed cancer patients survived for a median of roughly 12 months after receiving the treatment before their conditions worsened. In response, BLUE is 2.4% higher to trade at $186.80.

This price action is more of the same for bluebird stock, as the shares have enjoyed support from the 160-day moving average since early April, and over the past 12 months have gained almost 130%. They still have some ground to make up, however, to revisit their record high of $236.17 on March 13.

Analyst sentiment is mostly bullish. Of the 20 firms covering BLUE, 13 currently hold "strong buy" ratings. Further, the stock's average 12-month price target stands at $216.67 -- a 16% premium to current levels.

On the other hand, short interest is elevated. Although short interest on BLUE fell almost 5% during the most recent reporting period, it still accounts for 7.8% of the equity's total available float, or seven times bluebird bio stock's average daily trading volume.

Echoing this skepticism, BLUE's Schaeffer's put/call open interest ratio (SOIR) of 1.06 ranks higher than 97% of all comparable readings taken in the past year. In other words, options traders are more put-heavy than usual among contracts set to expire in three months or less.
 
 

“Buy This Stock Now!” - Expert Who Called 11x On TSLA

He called a rare 11x on Tesla…

But now, thanks to Elon & Trump’s new alliance…

He says there’s a new opportunity that could be 1,000x BIGGER than Tesla – and it could completely revolutionize a $23 Trillion market.

It’s trading for less than $5 per share right now…

But it won’t be under the radar for long.

Discover The 1,000x Bigger Elon Opportunity Here

GRAND SLAM COUNTDOWN

 
 

Featured Articles from Trusted Partners:

👀Learn How Dividends Create Passive Income for Life
Receive $200 Off Motley Fool Epic. The Motley Fool Epic $299 discounted offer is based on $499/year list price. Introductory promotion for new members only. Take control of your money and your portfolio with Motley Fool Epic.

💵New Income System Could Pay You $4,243 Monthly
You could collect an average of $4,243 per month starting as early as next week with a new payout system for income investors. New registrations are being accepted for investors who want to be in a position to start with their first payout next week.

🚀Easy 92% Crypto Dividends (No Coins Required)
COIN stock doesn't pay a dividend... But there's actually a new way to collect a massive dividend that's indirectly based on the stock and offers a terrific monthly income (currently yielding nearly 92% on a forward basis).

🤝Free Advisor Match with Wiseradvisor.com
Don't leave your retirement to chance! Get matched with a trusted financial expert for FREE and make the most of your tax refund. Get started now.

⚠️Dennis Quaid's #1 Warning for Americans
Here's the thing: life doesn't come with guarantees. The economy shifts, markets stumble, and years of hard work could slip through your fingers like sand. But it doesn't have to be that way for you. So request a free copy of this Gold & Silver Guide that will arrive right to your doorstep when you act now.

 

 
 

Follow us on X, Follow us on Twitter